PureHelix™ Genomic Prep Kit [Blood] (Solution based)
- Known as:
- PureHelix™ Genomic Prep Kit [Blood] (Solution based)
- Catalog number:
- GSB100
- Product Quantity:
- 100 preps/kit
- Category:
- -
- Supplier:
- NanoHelix
- Gene target:
- PureHelix™ Genomic Prep Kit [Blood] (Solution based)
Ask about this productRelated genes to: PureHelix™ Genomic Prep Kit [Blood] (Solution based)
- Gene:
- PREP NIH gene
- Name:
- prolyl endopeptidase
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 6q21
- Locus Type:
- gene with protein product
- Date approved:
- 1996-03-12
- Date modifiied:
- 2016-10-05
Related products to: PureHelix™ Genomic Prep Kit [Blood] (Solution based)
Human ELC ELISA KIT 96 TEST
OxiSelect In Vitro ROS/RNS Assay Kit (Green Fluorescence), Trial Size
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size
OxiSelect Total Antioxidant Capacity (TAC) Assay Kit, Trial Size
OxiSelect™ In Vitro ROS RNS Assay Kit (Green Fluorescence), Trial Size(+)_1_(9_Fluorenyl)ethyl chloroformate 0.5 w_v% solution in ac(1-Kit )11,12-EET DHET Immunoassay Kit(1-Kit )11,12-EET_DHET Immunoassay Kit(1-Kit) 11,12-DHET Immunoassay Kit(1-Kit) 14,15-DHET Human Urine ELISA Kit(1-Kit) 14,15-DHET Hypertension ELISA Kit(1-Kit) 14,15-DHET sEH activity ELISA Kit(1-Kit) 14,15-EET DHET Hypertension ELISA Kit Related articles to: PureHelix™ Genomic Prep Kit [Blood] (Solution based)
- This study aims to determine the agility level of the prehospital emergency medical services (EMS) organization and to examine the impact of organizational agility (OA) on prehospital emergency health care professionals' perception of disaster preparedness using a structural equation model (SEM). - Source: PubMed
Publication date: 2026/09/22
Bek Yağmur Özlem - Gonorrhoea incidence is increasing globally, with gay and bisexual men (GBM) over-represented in notifications. Changes in behaviour, sexual networks and screening practices associated with HIV pre-exposure prophylaxis (PrEP) uptake and treatment-as-prevention may influence gonorrhoea transmission. We describe trends in gonorrhoea testing and incidence among GBM over 12 years spanning PrEP implementation in Australia. - Source: PubMed
Publication date: 2026/09/21
Aung Hein HtetWilkinson Anna LGuy RebeccaAsselin JasonAung Htein LinnChow Eric P FOng Jason JVarma RickThng CarolineShaw MarcusLee Frederick JTempleton David JKong Fabian Yuh ShiongWatson NyssaCornelisse Vicent JHeath-Paynter DashHellard Margaret EStoove Mark ATraeger Michael W - Microbial proteases are among the most commercially important enzyme groups, contributing approximately 20% of the global industrial enzyme market because of their broad substrate specificity, operational robustness, and cost-effectiveness. These enzymes catalyze peptide bond hydrolysis under mild and environmentally benign conditions, supporting cleaner manufacturing and circular bioeconomy strategies. This review focuses on the production, engineering, and industrial application of microbial proteases, with particular emphasis on the valorization of protein-rich agro-industrial, food, and animal-processing residues generated in multi-million-ton quantities annually. The review adopts a circular bioprocessing perspective that links protease performance with waste-stream conversion, process integration, and resource-efficiency outcomes. Applications in food and feed processing, detergent formulations, leather processing, and protein hydrolysate production are critically discussed in the context of sustainable industrial processing. Advances in enzyme engineering, secretion and production optimization, and integrated bioprocess design are examined alongside key technical and economic constraints. Future progress will depend on the development of robust proteases, intensified and continuous processing platforms, and decentralized waste-to-value systems supported by improved process monitoring and standardized product characterization. - Source: PubMed
Publication date: 2026/09/21
Nasir NazneenNaik KratikaDsouza Melvin VincentSoudagar Sahar BanuEelager Manjunath PDodamani SuneelParthasarathy MDalbanjan Nagarjuna Prakash - Pre-exposure prophylaxis (PrEP) effectively reduces HIV incidence among South African adolescent girls and young women (AGYW), but barriers to access and sustained use remain. We evaluated the effects of a clinic-level stigma and discrimination (S&D) training and the Young Women's Health CoOp (YWHC) intervention on oral PrEP outcomes among AGYW aged 16-24 years (N = 802) in Tshwane (Pretoria), South Africa. Using a modified 2 × 2 factorial cluster-randomized trial, 12 clinics and their catchment areas were assigned to one of four study arms based on receipt of S&D training for clinic staff and delivery of the YWHC intervention to AGYW. Outcomes included PrEP readiness (self-report), uptake (medical records), adherence, and persistence (dried blood spots), measured at baseline and 3-, 6-, and 9-month follow-up. Multilevel modeling showed that PrEP readiness scores were higher at follow-up among AGYW in the control arm than among those in intervention arms (p < 0.05). Differences in PrEP uptake were not statistically significant (p = 0.11), although they were clinically meaningful. AGYW attending clinics that received S&D training were more than twice as likely to initiate oral PrEP as participants in the control arm. AGYW who received the YWHC intervention were more likely to adhere to oral PrEP than those in the control arm (p ≤ 0.05). Participants in all intervention arms were also more likely to persist with PrEP use over time than controls (p < 0.05). These findings suggest that clinic- and individual-level interventions can optimize PrEP initiation, adherence, and persistence among AGYW. - Source: PubMed
Publication date: 2026/09/21
Bonner Courtney PeasantMinnis Alexandra MBrowne Felicia ASpeizer Ilene SNyblade LauraNdirangu Jacqueline WKline Tracy LSmith AyannaAhmed KhatijaWechsberg Wendee M - The morbidity and mortality associated with landmines and explosive remnants of war remain a significant problem worldwide. Deminers exposed to these hazards repeatedly in their line of duty have not had their injury patterns adequately synthesized in over two decades and mine contamination continues to expand in modern conflicts.A systematic review was conducted in accordance with PRISMA 2020 guidelines. Inclusion criteria were studies that documented injury patterns, injury mechanisms, personal protective equipment (PPE), and outcomes in deminers.Eight studies published between 1990 and 2025 met the inclusion criteria. Demining activities were associated with high injury and fatality rates across all studies. Most injuries involved handling anti-personnel mines; upper limb trauma (62%) and amputations, which were commonly reported, distinguished deminers from other civilian and military populations exposed to explosive devices. Despite improvements in personal protective equipment, facial and ocular injuries remain prevalent. Deminers had better survival rates than civilians, often due to rapid evacuation and on-site medical support; however, only 20% returned to clearance work post-injury. Contributing risk factors included procedural lapses, inadequate training, and poor supervision.Although advancements have improved safety, current evidence remains limited and outdated. Systematic injury reporting and updated analysis of injury data are urgently needed. - Source: PubMed
Publication date: 2026/09/21
Hickson BlaiseLloyd Emma RachelMoon Kyung HoonGargan TimothyEisenstein Neil